Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
November 30, 1999

Merck and Company Aldoril D50 Tablets Recalled

West Point, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Merck and Company is recalling Aldoril D50 Tablets, (Methyldopa (500mg)-Hydro-chlorothiazide (50mg)), in 100 Tablet bottles, a Rx used to control hypertension with the NDC #0006-0935-68, because of dissolution failure for Hydrochlorothiazide.

This ongoing Class III recall was initiated by the company, September 23, 1999 by letter.  This is the first notice the FDA has issued to the general public of the recall.

Over 15,000 bottles were distributed nationwide and bear the lot numbers and expiration dates of B5511 EXP 1/00, D5714 EXP 4/00, D5719 EXP 4/00, E6156 EXP 4/00, E6172 EXP 2/00 or H3896 EXP 4/00.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.